Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer

Lu Zhang, Jerry W. Shay

Research output: Contribution to journalReview article

33 Citations (Scopus)

Abstract

Adenomatous polyposis coli (APC) is widely accepted as a tumor suppressor gene highly mutated in colorectal cancers (CRC). Mutation and inactivation of this gene is a key and early event almost uniquely observed in colorectal tumorigenesis. Alterations in the APC gene generate truncated gene products, leading to activation of the Wnt signaling pathway and deregulation of multiple other cellular processes. It has been a mystery why most patients with CRC retain a truncated APC protein, but accumulating evidence suggest that these C terminally truncated APC proteins may have gain of function properties beyond the well-established loss of tumor suppressive function. Here, we will review the evidence for both the loss of function and the gain of function of APC truncations and how together they contribute to CRC initiation and progression.

Original languageEnglish (US)
Article numberdjw332
JournalJournal of the National Cancer Institute
Volume109
Issue number8
DOIs
StatePublished - Aug 1 2017

Fingerprint

Adenomatous Polyposis Coli
Adenomatous Polyposis Coli Protein
Colorectal Neoplasms
APC Genes
Wnt Signaling Pathway
Gene Silencing
Tumor Suppressor Genes
Carcinogenesis
Therapeutics
Mutation
Genes
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

Cite this

Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer. / Zhang, Lu; Shay, Jerry W.

In: Journal of the National Cancer Institute, Vol. 109, No. 8, djw332, 01.08.2017.

Research output: Contribution to journalReview article

@article{d23b49f56f8a435b94db50234497d2b3,
title = "Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer",
abstract = "Adenomatous polyposis coli (APC) is widely accepted as a tumor suppressor gene highly mutated in colorectal cancers (CRC). Mutation and inactivation of this gene is a key and early event almost uniquely observed in colorectal tumorigenesis. Alterations in the APC gene generate truncated gene products, leading to activation of the Wnt signaling pathway and deregulation of multiple other cellular processes. It has been a mystery why most patients with CRC retain a truncated APC protein, but accumulating evidence suggest that these C terminally truncated APC proteins may have gain of function properties beyond the well-established loss of tumor suppressive function. Here, we will review the evidence for both the loss of function and the gain of function of APC truncations and how together they contribute to CRC initiation and progression.",
author = "Lu Zhang and Shay, {Jerry W.}",
year = "2017",
month = "8",
day = "1",
doi = "10.1093/jnci/djw332",
language = "English (US)",
volume = "109",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer

AU - Zhang, Lu

AU - Shay, Jerry W.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Adenomatous polyposis coli (APC) is widely accepted as a tumor suppressor gene highly mutated in colorectal cancers (CRC). Mutation and inactivation of this gene is a key and early event almost uniquely observed in colorectal tumorigenesis. Alterations in the APC gene generate truncated gene products, leading to activation of the Wnt signaling pathway and deregulation of multiple other cellular processes. It has been a mystery why most patients with CRC retain a truncated APC protein, but accumulating evidence suggest that these C terminally truncated APC proteins may have gain of function properties beyond the well-established loss of tumor suppressive function. Here, we will review the evidence for both the loss of function and the gain of function of APC truncations and how together they contribute to CRC initiation and progression.

AB - Adenomatous polyposis coli (APC) is widely accepted as a tumor suppressor gene highly mutated in colorectal cancers (CRC). Mutation and inactivation of this gene is a key and early event almost uniquely observed in colorectal tumorigenesis. Alterations in the APC gene generate truncated gene products, leading to activation of the Wnt signaling pathway and deregulation of multiple other cellular processes. It has been a mystery why most patients with CRC retain a truncated APC protein, but accumulating evidence suggest that these C terminally truncated APC proteins may have gain of function properties beyond the well-established loss of tumor suppressive function. Here, we will review the evidence for both the loss of function and the gain of function of APC truncations and how together they contribute to CRC initiation and progression.

UR - http://www.scopus.com/inward/record.url?scp=85021170291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021170291&partnerID=8YFLogxK

U2 - 10.1093/jnci/djw332

DO - 10.1093/jnci/djw332

M3 - Review article

C2 - 28423402

AN - SCOPUS:85021170291

VL - 109

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 8

M1 - djw332

ER -